CH-6370 Stans - Switzerland
T +41 (0)840 200 010
F +41 (0)840 200 011
mondoBIOTECH AG, a private Swiss biotechnology company, today announced the receipt of an Orphan Medicinal Product Designation (OMPD) by the European Commission for its product Aviptadil for the treatment of Acute Lung Injury (ALI) in the European Union (EU/3/06/395), after the positive opinion given by the European Medicinal Agency (EMEA).
Cambridge, MA and Basel, Switzerland
BIOGEN IDEC AND MONDOBIOTECH SIGN COLLABORATION AND LICENSING AGREEMENT TO DEVELOP AND COMMERCIALIZE AVIPTADIL FOR PULMONARY ARTERIAL HYPERTENSION